Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;37(11):e174-e177.
doi: 10.1161/ATVBAHA.117.310097. Epub 2017 Sep 28.

The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology

Richard A Baylis  1 , Delphine Gomez  1 , Ziad Mallat  1 , Gerard Pasterkamp  1 , Gary K Owens  2
Affiliations
Review

The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology

Richard A Baylis et al. Arterioscler Thromb Vasc Biol. 2017 Nov.

Abstract

The results of the CANTOS trial provide exciting evidence in support of the inflammatory hypothesis of atherosclerosis in humans, and is the first phase III clinical trial to show clinical benefit of a targeted anti-inflammatory therapy. However, the modest overall clinical benefit and safety concerns with increased susceptibility to fatal infections indicate that we need much more work in this critical area.

Keywords: atherosclerosis; coronary artery disease; inflammation; interleukins; translational medical research.

PubMed Disclaimer

References

    1. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017 - PubMed
    1. Harrington RA. Targeting Inflammation in Coronary Artery Disease. N Engl J Med. 2017 - PubMed
    1. Pasterkamp G, Ruijter den HM, Libby P. Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease. Nature Publishing Group. 2017;14:21–29. - PubMed
    1. Kanwar SS, Stone GW, Singh M, Virmani R, Olin J, Akasaka T, Narula J. Acute coronary syndromes without coronary plaque rupture. Nature Publishing Group. 2016;13:257–265. - PubMed
    1. Franck G, Mawson T, Sausen G, Salinas M, Masson GS, Cole A, Beltrami-Moreira M, Chatzizisis Y, Quillard T, Tesmenitsky Y, Shvartz E, Sukhova GK, Swirski FK, Nahrendorf M, Aikawa E, Croce KJ, Libby P. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion. Circulation Research. 2017;121:31–42. - PMC - PubMed

Publication types

MeSH terms